PDGFß receptor-targeted delivery of truncated transforming growth factor ß receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-ß1/Smad signaling pathway.
Naunyn Schmiedebergs Arch Pharmacol
; 397(1): 237-252, 2024 01.
Article
in En
| MEDLINE
| ID: mdl-37401970
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Transforming Growth Factor beta1
/
Kidney Diseases
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Naunyn Schmiedebergs Arch Pharmacol
Year:
2024
Document type:
Article